Byooviz Archives -

The US FDA has approved a new biosimilar of Roche and Novartis’ blockbuster ophthalmology therapy Lucentis – Coherus

Pressure rises on Lucentis, as Coherus biosimilar gets FDA nod

https://pharmaphorum.com/news/pressure-rises-on-lucentis-as-coherus-biosimilar-gets-fda-nod/

Samsung Bioepis and Biogen have claimed the first FDA approval for a biosimilar version of Roche and Novartis’

FDA OKs first biosimilar of Roche’s blockbuster AMD drug Lucentis

https://pharmaphorum.com/news/fda-oks-first-biosimilar-of-roches-blockbuster-amd-drug-lucentis/

Novartis and Roche’s big-selling eye drug Lucentis has its first biosimilar competitor in Europe, after the European Commission

Europe has its first Lucentis biosimilar, Samsung Bioepis’ Byooviz

https://pharmaphorum.com/news/europe-has-its-first-lucentis-biosimilar-samsung-bioepis-byooviz/

Byooviz